November 6, 2025 Zhu Lab shows location matters for liver cancer’s origins Hepatocellular carcinoma arises primarily in zone 3 due to glutathione transferase genes that help…
October 23, 2025 Mishra, Zhu selected to develop in vivo genetic screens to identify new regulators of liver trauma
Regenerative Medicine June 19, 2024 PKD1 mutant clones within cirrhotic livers inhibit steatohepatitis without promoting cancer Summary: Somatic mutations in non-malignant tissues are selected for because they confer increased clonal…
Regenerative Medicine April 10, 2023 Mutant clones in the liver may fight fatty liver disease Somatic mutations in nonmalignant tissues accumulate with age and injury, but whether these mutations…
July 7, 2021 Dr. Corbitt selected to be Dedman Scholar Natasha Corbitt, M.D., Ph.D., a researcher in the Zhu lab at CRI and a…
Regenerative Medicine February 25, 2021 Scientists identify cells responsible for liver tissue maintenance and regeneration While the amazing regenerative power of the liver has been known since ancient times,…
February 1, 2021 Hao Zhu receives Mark Foundation for Cancer Research 2021 Emerging Leader Award Hao Zhu, M.D., an associate professor at CRI, was one of seven researchers selected…
October 29, 2020 The possibility of immunotherapy for liver cancer prevention Chronic liver damage raises the risk of developing hepatocellular carcinoma (HCC) – the most…
September 7, 2020 Researchers show how mutations in DNA packaging machines cause cancer Like wrenches made of Legos, SWI/SNF chromatin remodeling complexes tighten or loosen DNA in…